Related Experiment Video
Updated: Aug 15, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
The effect of dimethylaminoadamantane on neuronal membranes
Dimethylaminoadamantane (DMAA), an anti-Parkinson drug, was found to reduce nerve fiber spike amplitude and ion permeability in rats. These membrane effects may influence its action on brain dopaminergic transmission.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Amantadine derivatives are used for Parkinson's disease.
- Dimethylaminoadamantane (DMAA) is an amantadine derivative with anti-Parkinson properties.
Purpose of the Study:
- To investigate the effects of DMAA on rat sensory nerve fibers.
- To understand the potential mechanisms behind DMAA's anti-Parkinson activity.
Main Methods:
- Sucrose gap method was used to study rat sensory nerve fibers.
- Experiments involved varying ion concentrations (sodium, potassium, calcium, chloride) in the suspension medium.
Main Results:
- DMAA (10^-4 M) reduced spike amplitude and repetitive spike activity.
- DMAA increased membrane resistance without altering resting potential.
- DMAA reduced the permeability of sodium, potassium, and chloride ions.
Conclusions:
- DMAA exerts significant effects on nerve fiber membrane properties.
- These membrane effects, including reduced ion permeability, may contribute to DMAA's influence on dopaminergic transmission in the brain.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis